European Patent Office

T 0750/18 vom 20.12.2021

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2021:T075018.20211220
Datum der Entscheidung
20. Dezember 2021
Aktenzeichen
T 0750/18
Online am
7. März 2022
Antrag auf Überprüfung von
-
Anmeldenummer
09789380.4
IPC-Klasse
C07D 489/12
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
PROCESSES FOR THE ALKYLATION OF NORBUPRENORPHINE WITH REDUCED IMPURITY FORMATION
Name des Antragstellers
Mallinckrodt LLC
Name des Einsprechenden
isarpatent - Patent- und Rechtsanwälte Behnisch
Barth Charles Hassa Peckmann und Partner mbB
Johnson Matthey Public Limited Company
Kammer
3.3.02
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention R 139European Patent Convention Art 123(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Schlagwörter
Correction of error - (no)
Amendments - added subject-matter (yes)
Statement of grounds of appeal - complete case (yes)
Statement of grounds of appeal - No need to raise objections against all dependent claims
Late-filed test results - admitted (no)
Inventive step - auxiliary request 5 (no)
Reply to grounds of appeal - complete case (no) - auxiliary request not substantiated
Amendment of the case after summons - exceptional circumstances (no) - auxiliary request 6 admitted (no)
Orientierungssatz
The requirement under Article 12(2) RPBA 2007 to present a complete case does not imply that an appellant/opponent, impugning a decision to maintain a patent in granted or amended form, has to raise objections against all dependent claims (point 4.2 of the reasons).
Zitierende Akten
-

Order

For these reasons it is decided that:

1. The appealed decision is set aside.

2. The patent is revoked.